RE:ANGRY[quot7e=Pedal2themetal7]
Sorry about the format, but I compiled a few examples below, and if you look at Sundial at a SP $2.38 expected sales of 62.6 million this coming year and Cronos SP $12.15 sales of 86.9 million, Supreme might beat Sundial and closing the gap with Cronos with a share price of .40. We all know about Organigram and their SP. The below paragraph gives a pretty good idea what investors are looking at when investing in the "big" league, Canopy with 829 million loss is astronomical and yet people were complaining about our losses!!!!!!!
Canopy with 152.5 million revenue and 829 million loss and Aurora reporting 67.7 million revenue and an adjusted EBITDA losses of C$16.8 million.
I strongly believe Supreme will have one of the strongest balance sheet at the end of 2021, so hopefully now that Beena has proven the company can deliver, analysts and the market will react accordingly.
Company / Ticker Market Cap (bil) Feb. 11 Close Avg. Price Target Estimated Next FY Sales (mil)
Tilray / TLRY $10.1B $32.16 $12.20 $277.80
Aphria / APHA 8.3 16.88 12.6 710.3
Sundial Growers / SNDL 4.3 2.38 0.3 62.6
Aurora Cannabis / ACB 3.7 14.47 9.07 303.3
Canopy Growth / CGC 19.7 40.65 37.75 639.9
Cronos Group / CRON 4.3 12.15 6.51 86.9
Sundial Growers (SNDL)
(Sundial)The stock bounced back this month amid retail trader interest, it’s up 403% year-to-date. Its market value is at $4.3 billion after Thursday’s pullback. Expected sales to hit $53.1 million for full-year 2020. Consensus estimates call for $62.6 million in 2021.
Canopy Growth Q3 earnings $152.5 million revenue and an $829 million loss.
Aurora Cannabis Q2 earnings $67.7 million in revenue and an adjusted EBITDA losses of C$16.8 million.
IMHO
[/quote]
excellent data ped.. i fully agree at some point given comparisons.. the world has to take notice .. we should be valued much much higher cheers again appreciated